chrisvoncsefalvay/vaers-outcomes huggingface dataset:
kind of tired; arm hurt; started getting these little twitches; This is a spontaneous report from a contactable consumer (patient).  A female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration on Aug2021 as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in Aug2021, the patient had experienced kind of tired, arm hurt and getting these little twitches. At the time of reporting, the outcome of the events were unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
I had had a severe reaction to the flu shot I received on 9/28/21...developed Bell's Palsy.  The symptoms lasted a few weeks.  Most of the symptoms resolved, but I still have areas of weird sensations that has not gone away. For the immediate treatment, I was given a prescription for steroids and was told I shouldn't have any additional problems for future vaccinations.    I was scared to get the COVID vaccine thinking I could have another severe reaction, but I was assured it should not happen again.  I had the COVID vaccine on 3/10/21.  Yesterday, 3/24/21, exactly 2 weeks to the day, I'm feeling like the Bell's Palsy symptoms are returning.  I have  had a large fever blister on my mouth and one side of my face is feeling somewhat numb.
Per COVID Vaccine Clinic nurse, employee/pt was screened for ASE and asked to stay for 30 minutes after immunization at 1430 on 02/08/2021; pt did not report any s/sx of anaphylaxis and left the COVID Vaccine Clinic at 1500 on 02/08/2021.   Per Dr. from Care Center, which is located in the same building as the employee's COVID-19 Vaccine Clinic, pt returned at 1545 on 02/08/2021 reporting  "generalized itching as well as nausea and feeling of swelling and itching n her throat and bilateral ears." She was treated by employer's ICC for s/sx of anaphylaxis and given epinephrine 1 mg/mL 0.5 mL IM, cetirizine 10 mg PO, and Prednisone 60 mg PO. Per ICC, pt was monitored for 1 hour, symptoms resolved, and she was advised to "go to the ER if she has return of symptoms, but this is unlikely."
2 weeks post Covid-19 vaccine started a severe case of Hives, later diagnosed with chronic urticaria. I remained with suffered flares 10 months later.
Hives, Red raised places on my skin, itching , painful joints and swelling at the joints, cold fingertips, chills
Pt slept for 12 hrs p/vax; started to run fever the following day; mom reports wouldn't nurse for 2 days; took very little cereal; refused bottle or cup;  when put to breast would start to scream & cry went to ER on 13FEB; dx'd w/ear infect
Body aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches) and CHILLS (chills) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021F21B, 021C21A and 0441321A) for COVID-19 vaccination. No Medical History information was reported. On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, the patient experienced MYALGIA (Body aches) and CHILLS (chills). On 03-Dec-2021, MYALGIA (Body aches) and CHILLS (chills) had resolved. Patient had body aches and chills for 3 hours after the booster. Patient might  had Covid-19 in FEB/2020 since he was very sick at that time, however was not diagnosed as Covid-19. It was reported that patient thinks she received her Moderna Booster dose on 03-DEC-2021.No Concomitant medication reported. No Treatment medication reported. This case was linked to MOD-2021-406202, MOD-2021-406148 (Patient Link).
Had the 2 shot regimen, have had it (shingles) twice since/Suspected vaccination failure; Had the 2 shot regimen, have had it (shingles) twice since; Pain is really bad; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included pain. Previously administered products included Shingles vaccine with an associated reaction of herpes zoster (received when he/she was old enough then got shingles 15 years later, very painful but he/she was lucky to only had a silver dollar spot on his/her back).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 23-SEP-2022 Reporter's Comment: The patient self-reported this case via interactive digital media and described the occurrence of suspected vaccination failure. The patient had the 2 shot regimen and had it (Shingles) twice since.  The patient stated that the pain was really bad but he/she guessed he/she was lucky that it hadn't gotten larger. The patient also stated that his/her doctor asked him/her only got it twice, patient guessed it could happen a lot. Additional supportive information: This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not possible, as no contact, details were available. This case had been linked with case US2022AMR140079, reported by the same reporter.; Sender's Comments:  US-GSK-US2022AMR140079:tag at post
Patient signed up for Pfizer first dose vaccine at the pharmacy and marked patient ever received a dose of COVID-Vaccine. Pharmacist ran check also didn't see any other COVID vaccine administered. However, pharmacy received insurance rejection that another COVID vaccine was administered. Pharmacy called patient's insurance and was directed to to Pharmacy and was informed patient received Janssen COVID vaccine on 4/6/2021. Called patient to confirm, but couldn't reach the patient. Left voice message to patient to call back
pt recvd vax & 8 hrs later awoke w/abdo pain, abdo cramps, nausea & vomiting; events were reported to be severe; There no diarrhea or fever; The individual did not seek med attention;
1 day after vaccine, experienced swelling in left armpit. Chills, fever, fatigue, headache. Swelling in armpit is continuing through second day followimg.
Presents to hospital with c/o significant weakness since receiving first Moderna Covid vaccination on 3/26. Pt notes weakness started on 3/29.
Noticed left arm swollen, slight pain at site on 1-18-07 late pm. Seen at health dept 1-19-07-LA swollen-no reddness, no warmth to touch-has MD appt 1-22-07.  Will eval if needed at that time.
Approximately 12 hours post vaccine, she started experiencing intense muscle spasms/twitching and chills. This lasted approximately 3 hours. She stated she was unable to control her hands to work her phone to text or call for help. She stated she could not talk. After approximately 3 hours, she stated she got very flushed and then regained muscle control. She fell asleep amd felt fine when she awoke.
Expired vaccine was administered.  Expiration date 11/1/2021.  Date of vaccination 11/5/2021.
about 5 minutes after injection patient said she didn't feel right and was pale.  Her hands were cold and neck was warm.  I had technician call emergency services.  Patient then lots consciousness for a brief moment and mother and I tried to keep her talking.  I took her blood pressure (143/45) and O2 98%.  Her pulse was erratic and hard to read.  Fire department arrived and provided oxygen and retook her BP and O2.  EMTs arrived and transported patient to the hospital.
Patient received first dose of 2-dose Pfizer COVID-19 vaccine.  Approximately 24 hours after injection, patient experienced headaches.  Approximately 48-72 hours after injection, patient experienced left eye pain and developed a non-itch-inducing rash in left temple.  Following after this period, eye pain worsened, as did the size of rash (stretching from temple to back of left ear - along the V1 nerve).  Patient was diagnosed with Shingles and is now receiving treatment for that virus.  It is theorized that the vaccine induced an immune response to attack the novel virus, and left its guard down for the dormant Herpes Zoster virus.
26SEP95 pt noticed swelling in hands & feet & itching, no diff in breathing;28SEP95 pt devel hive-type rash on thighs;2OCT95 hives/swelling disappeared
Body ache, coughing, diarrhea, fever, chills, tiredness, body hurting
Left shoulder joint pain counseled patient to take Ibuprofen or ALEVE (Naproxen) and to keep us informed of worsening or additional symptoms.
redness surrounding the injection site; itching surrounding the injection site; This case was reported by a consumer and described the occurrence of injection site erythema in a patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2019, the patient received Shingrix. In August 2019, less than 2 weeks after receiving Shingrix, the patient experienced injection site erythema and injection site itching. The patient was treated with paracetamol (Tylenol), ambiguous medication nos (Claritin (Nos)), naproxen (Aleve) and cortisone (non-proprietary) (Cortisone Cream). On an unknown date, the outcome of the injection site erythema and injection site itching were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema and injection site itching to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The patient received initial Shingrix vaccination 10 days before the reportng date. The patient experienced redness and itchiness surrounding the injection site. The patient had tried Tylenol, Claritin, Alleve, and Cortisone cream, and nothing was alleviating the itch.  The patient would appreciate any suggestions.
fever, chills, headache, fatigue, sore muscles, stomach irritation.  Lasted 2 days.  Took Tylenol and rested.
Severe inflammation at injection site. Hard, red, swollen, hot, painful. Began 1 day post administration. Possible cellulitis being treated with CEFDINIR. Was 2nd dose (1 mo).
This medically confirmed spontaneous report (initial receipt 28-OCT-2014) concerns a 50 year old male patient. On 26-OCT-2014, AFLURIA underwent temperature excursion at 50 degree Fahrenheit. On 27-OCT-2014, AFLURIA again had temperature excursion at 50 degree Fahrenheit for undetermined amount of time. On 27-OCT-2014, the patient received temperature excursion AFLURIA (batch number: T50507) via intramuscular route at 0.5 ml. Outcome was reported as unknown. Reporter's comments: The reporter assessed the event as non-serious.
Patient was admitted to Hospice Care 02/2/2022 for COVID 19.  The patient expired on 02/28/2022.
PATIENT CAME IN TO GET THE NEW PFIZER BIVALENT VACCINE.  ON THE SELF IN THE FRIDGE BOTH VACCINES VIALS OLD PFIZER AND THE NEW BIVALENT .  TWO VIALS OF THE OLD PFIZER VACCINE WAS TAKEN OUT TO VACCINE PATIENT FOR THE NEW BIVALENT VACCINE.  AFTER TWO VIALS  WERE USED UP BEFORE WE REALIZING IT WAS THE WRONG VACCINE.
No adverse effects; patient was vaccinated with improperly stored MMR II; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.   01-MAR-2019, the patient was vaccinated with an improperly stored dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) lot # R008031 and expiration date 18-MAR-2020 for prophylaxis (dosage schedule, route, and anatomical location were not reported). Other suspect therapy was sterile diluent for prophylaxis (dosage schedule, route, anatomical location, lot number and expiration date were not reported). The administered dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) experienced a temperature excursion above 9 degrees Celsius (8.59 C) for 15 minutes, and for sterile diluent experienced a temperature excursion above 1.18 degrees Celsius for 33 hours, as recorded by a data logger. There was no previous temperature excursion. No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1905USA001733:
Admitted to local hospital for back pain and thigh pain. Tested positive for COVID prior to transfer to alternate local Centre Hospital.
Pt called approx. 4 hrs after shot administration complaining of swollen lips and eyes.
Day 1-2, dizzy, muscle weakness, shaky hands, heart rate up and down all day, palpitations, cold hands and feet, injection site pain, pain in both arms and hands Day 3-4, muscle weakness, shaky hands, glands in neck swollen, cold hands, extreme muscle fatigue, tingles in  feet. Day 5-30, muscle fatigue, hard to drive or type without getting tired muscles, shaky hands, pins and needles randomly in body, ache in joints,  tight muscles, weakness right side body.
High fever of 103° starting at around 8:30 pm on date of injection accompanied by chills and lethargy. Lasted over 24 hours.
It started with a cough, bad shakes, fever, fatigue, aches, pains, diarrhea, and nausea. I tested positive for COVID-19 at home on day four. I called my doctor the next day and they prescribed me PAXLOVID. I got better by the end of the week. But then the second week I had nothing but fatigue.
This spontaneous report as received from a Licensed Practical nurse refers to 8 patients of unknown age and gender. On 02-OCT-2012, the patients were vaccinated with GARDASIL (lot # 0420AE and expiry date was 02-NOV-2014, route and dose were not reported) that was exposed to 25 degree Fahrenheit for an unknown period of time. No concomitant medications were reported. No adverse symptoms reported. This is one of the several reports received from the same reporter (MARRS# 1212USA000914, 1212USA003709, 1212USA003710, 1212USA003711, 1212USA003712, 1212USA003713, 1212USA003714 and 1212USA004285) Additional information has been requested.
It's started with a sore throat and congestion in the nasal and sinus area. I also had a sore throat, achy with malaise and a low-grade fever of 99.4. I completed a COVID-19 home test and it was positive. The doctor prescribed Paxlovid. I started taking the medication on the 20th of January. I began to feel better on the 2nd day. My symptoms resolved by the 25th of January.
Client continued to converse/act normally post-vaccination about college plans, vaccination requirements, etc for approximately three minutes. LPN began getting a second set of vitals and as LPN turned around to fill out the immunization card while the machine was taking a 2nd blood pressure (one pre-vaccination), she saw out of the corner of her eye the pt start to fold over and fall off the side of the exam table, hitting her forehead on the wall on the way to the ground. LPN reports the time from vaccination to fainting to be no more than 3 minutes. At that point, she called for help and was assisted by me, RN. By the time I reached the room (<1minute post fainting episode), the pt was coherent and asking worriedly about what happened. LPN was supporting her head and neck and telling her to relax while she obtained another set of vitals. I brought her 2 ice packs to apply to her head and neck and called her mother to tell her what happened. Approximately 3 minutes after calling her mother and describing what happened, I notified EMS services and requested their assistance. <2 minutes later, EMS personnel arrived in our office to evaluate the pt. Pt was still pale and EMS reported a pulse ranging from the 40's to 90's with an irregular heart beat. Approximately 5 minutes after EMS arrived, the pts mother arrived and entered the room with the EMS personnel. EMS continued to monitor pts vital signs and glucose while she was lying on the floor x5 minutes. EMS suggesting heart rhythym monitor, so we moved the pt to the exam table. EMS monitored the heart rhythm and further assessed X15-20minutes. Pt asking for us to call and see if she go straight to her PCP's office from our office. I called and made arrangements for her to go straight to see her PCP, DO. While I was making an appointment for the pt to be seen immediately at her PCP's office (approximately 10minutes) she had signed EMS's refusal to be taken to the hospital and EMS had left, but LPN remained in the room with her monitoring her vital signs. Pt left our office at approximately 2:55pm.
I started getting symptoms of a sore throat and headache for 3-4 days then went away. I took an at home COVID-19 test that was positive. I contacted my doctor with a telehealth visit and was prescribed Paxlovid. After the Paxlovid, my symptoms went away.
On 11/05/2022 in the morning as soon as I woke up, I had a sore throat, cough, runny nose, unusual body aches, fever of 100.6, and weakness. On 11/07/2022 I did a telehealth with my doctor prescribed PAXLOVID, but I decided not to take. Instead, I took over the counter cold medications and vitamin C.
Flu  like symtoms for 4 days, -brain fog and loss of energy still going on since had shot 3 months ago -severe joint pain all over body for almost a month  -still experiencing inflamation, joint pain in hands and feet 3 months plus- had not ended yet. still ongoing -nerve pain in hands and feet- ongoing 3 months later
This spontaneous report as received from a healthcare worker refers to an unspecified patients of unspecified age and gender. The patients concurrent conditions and medical history was not reported. The healthcare worker reported that, on an unspecified dates, an unspecified number of unspecified patients were administered with improperly stored doses of ROTATEQ with lot# L037924 and expiration date: 22-JUN-2017; with lot # L039297 and expiration date: 19-JUN-2017; with lot # L008578 and expiration date: 14-DEC-2016; with lot # L027726 and expiration date: 10-MAY-2017 (strength, dose number and dosage unspecified) via oral route. The vaccine was exposed to temperature of 10.1 degree C for time frame of 1 hour, there was no previous temperature excursion. No adverse effect was reported. No product quality complaint (PQC) was involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
16 year old received Moderna vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received Moderna vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Oct-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received Moderna vaccine). On 15-Oct-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug details were reported. No treatment details were reported.
Arm hurts - can?t pick up heavy objects anymore. Trouble breathing and Pains  Bones ache and arm hurts keeps me up at night Swollen lymph node in my neck
Chest pain; tightening across chest; Significant body aches and pain throughout the night; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 12:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included birth control. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified medication for birth control from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 19Apr2021 at 20:45, the patient experienced chest pain and tightening across chest, this was what came at onset of symptoms about 8 hours post vaccine. On 19Apr2021, the patient experienced significant body aches and pain throughout that night. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pain, tightening across chest, body aches and pain throughout the night was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Hematuria with clot. Covid booster was given on 1/27/22 Health young adult experienced sudden frank hematuria with large clot. This required ER visit. Urinalysis also positive for protein
Information has been received from a physician concerning a 7 year old male patient who on 21-AUG-2008 was vaccinated with a second dose of VARIVAX (Merck) (lot # 660499/0132X). On 09-SEP-2008 the patient was seen in the physician's office with the complaint of chicken pox. The patient's brother also developed chicken pox after vaccination with VARIVAX (Merck) (WAES # 0809USA02379). Additional information hs been requested. This is one of several reports from the same source.
Pain, redness, swelling, warmth at injection site began 1 week after receiving vaccine
Approximately 55 hours (2 Days) post vaccine the patient developed her first ever seizure. She was hospitalized at another facility. She has no history of egg or any other medication allergy. Patient was not on any new drugs prior to the reaction. 12/08/08 Discharge summary, ED and Hospital records received for DOS 12/02/09-12/04/09  Pt. presented with h/o headache x 3 days.  Sudden onset of feeling hot and nauseated today.  EMS responded; upon arrrival pt. c/o numbness of left arm and left side and had seizure which lasted 3 minutes. Post-ictal confusion and combativeness. Admitted for neuro monitoring. All symptoms resolved; no further seizure activity. Discharged stable;  f/u with neurologist and outpatient EEG. Impression: seizure activity ? etiology